MDxHealth has launched a noninvasive, urine-based test, SelectMDx for Prostate Cancer, in Europe via the company’s state-of the-art laboratory facilities in Nijmegen, the Netherlands. MDxHealth is offering SelectMDx patient testing initially in the Netherlands, with plans to expand the offering to other European countries in early 2016. In conjunction with the commercial launch of the […]
